QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CNC

QT74Centene Corporation
NYSE·Healthcare·Medical - Healthcare Plans·USA
Latest market price
61.02
+0.38+0.63%
OverviewShort InterestFilings
CNCQT74Centene Corporation·NYSE
OverviewShort InterestFilings
61.02+0.63%
TA
Loading chart...
Screen all →
UNH+0.36%$400.96CVS-0.85%$98.32ELV-0.71%$388.50CI-2.04%$279.27HUM-0.37%$360.65MOH-0.08%$195.37OSCR+0.46%$28.40ALHC+2.05%$21.86
Snapshot
Index-P/E-EPS (ttm)-13.14
Insider Own2.83%
Shs Outstand493.80M
Perf Week-3.97%
Market Cap29.94BForward P/E13.56EPS next Y4.50Insider Trans-0.02%Shs Float-Perf Month3.16%
Enterprise Value25.05BPEG0.02EPS next Q1.05Inst Own-Short Float-Perf Quarter71.55%
Income-6464877232.00P/S0.15EPS this Y126.51%Inst Trans-Short Ratio-Perf Half Y56.58%
Sales198.03BP/B1.39EPS next Y29.16%ROA-7.94%Short Interest-Perf YTD48.29%
Book/sh43.54P/C4.16EPS next 5Y27.51%ROE-28.72%52W High66.55 -8.31%Perf Year11.13%
Cash/sh48.08P/FCF4.72EPS past 3/5Y-ROIC-17.70%52W Low25.08 143.30%Perf 3Y-
Dividend Est.-EV/EBITDA-5.64Sales past 3/5Y10.45% 11.88%Gross Margin14.93%Volatility2.74% 2.41%Perf 5Y-
Dividend TTM-EV/Sales0.13EPS Y/Y TTM-60.06%Oper. Margin-3.68%ATR (14)2.34Perf 10Y-
Dividend Ex-Date-Quick Ratio1.12Sales Y/Y TTM21.48%Profit Margin-3.25%RSI (14)54.04Recom2.64
Dividend Gr. 3/5Y-Current Ratio1.12EPS Q/Q16.21%SMA20-0.76%Beta0.32Target Price59.00
Payout0.00%Debt/Eq0.76Sales Q/Q7.13%SMA5013.53%Rel Volume1.85Prev Close60.64
Employees60,400LT Debt/Eq0.93EarningsJul 28SMA20045.12%Avg Volume6.01MPrice61.02
IPO DateDec 13, 2001Option/ShortYes / YesEPS/Sales Surpr.51.12% 5.08%Net Debt/EBITDA1.10Volume11,087,106Change0.63%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-08-26ReiteratedMizuho Securities$58 → $63
Jun-04-26ReiteratedMorgan StanleyEqual Weight$38 → $57
Jun-01-26ReiteratedTruist Financial$58 → $71
May-26-26ReiteratedBarclaysOverweight$63 → $75
May-22-26ReiteratedUBSNeutral$42 → $61
May-20-26ReiteratedMizuho Securities$50 → $58
May-20-26UpgradeDeutsche BankHold → Buy$39 → $80
Apr-29-26ReiteratedTruist Financial$49 → $58
Apr-29-26ReiteratedGoldman SachsSell$32 → $40
Apr-29-26ReiteratedRaymond JamesMarket Perform$60
Latest News
Jun-18-26
Jun-18-2606:48PM
Modesto Residents Will Gain Access to More Affordable Homes Due to $4 Million Health Net InvestmentYahoo
Jun-17-26
Jun-17-2601:40PM
Should Value Investors Buy Centene (CNC) Stock?Yahoo
Jun-16-26
Jun-16-2603:47PM
Centene offers buyouts to workers as Obamacare enrollment slidesYahoo
03:44PM
Why Did UnitedHealth Stock Choose Pain Over Growth?Yahoo
01:53PM
Membership Slump Forces Health Giant Centene Into Staff Buyouts: ReportBenzinga
01:30PM
MHS Launches Statewide Program to Help Indiana Medicaid Members with EmploymentYahoo
12:00PM
Superior HealthPlan Recognized as a Best Place for Working Parents® in TexasYahoo
09:34AM
Centene offers employee buyouts amid membership lossesYahoo
Jun-15-26
Jun-15-2607:46PM
Sector Update: Healthcare Stocks Softer Late AfternoonYahoo
07:24PM
3 Reasons to Avoid CNC and 1 Stock to Buy InsteadYahoo
07:17PM
CNC Stock Falls 4% As Centene Reportedly Eyes Employee Buyouts Amid Membership DeclineYahoo
04:04PM
Centene to offer buyouts to some employees as health insurer cuts costsCNBC
01:53PM
'Centene Offers Most Staff Buyouts After Obamacare Member Losses' - BloombergBenzinga
01:00PM
3 Unprofitable Stocks That Concern UsYahoo
Jun-12-26
Jun-12-2605:18PM
MOH Wins Illinois Medicaid Contract, Reinforcing Long-Term StabilityYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue198,101194,777163,071
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A168,531170,944146,242
Gross Profit29,57023,83316,829
Selling, General and Administrative Excl. Other13,30713,26312,400
Research and Development
000
Other Operating Expense23,55518,1891,254
Operating Income-7,291-7,6183,175
Interest Expense672678702
Unusual Expense
———
Non-Operating Income (Expense)-1,588-1,203-1,784
Net Income Before Taxes-6,375-6,7284,257
Income Taxes77-51963
Consolidated Net Income-6,443-6,6733,305
Net Income From Continuing Operations-6,450-6,6773,294
Net Income-6,443-6,6733,305
EPS (Recurring)-13.12-13.616.33
EPS (Basic, Before Extraordinaries)-13.12-13.616.33
EPS (Diluted)-13.14-13.626.31
EBITDA-4,443-5,1406,200
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.150.10—
Gross Margin14.9312.2410.32
Operating Margin-3.68-3.911.95
Net Margin-3.25-3.432.03
Shares Outstanding492491522
Market Capitalization30,02220,205—
Operating Lease Expense
———
Insider Trading Volume
$71.30$63.67$56.04$48.41$40.78● Close Price0.00M1.29M2.58M3.87M5.16MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Burdick Kenneth ADirectorJun 10 '26Sale64.5580,0005,164,000197,086Jun 11 12:00 AM
Burdick Kenneth ADirectorDec 04 '25Sale39.0032,7961,279,044272,365Dec 05 12:00 AM
Burdick Kenneth ADirectorDec 03 '25Sale39.0433,2111,296,557305,161Dec 05 12:00 AM
LONDON SARAHChief Executive OfficerAug 08 '25Buy25.5019,230490,365845,275Aug 11 12:00 AM
Samuels Theodore R. IIDirectorJul 28 '25Buy27.629,000248,58032,000Jul 29 12:00 AM
Greco ThomasDirectorDec 18 '24Buy59.7517,0001,015,75019,309Dec 19 12:00 AM
Dallas H JamesDirectorDec 16 '24Buy59.011,69399,9041,693Dec 17 12:00 AM
BLUME JESSICA L.DirectorDec 16 '24Buy59.4825014,870250Dec 17 12:00 AM
COUGHLIN CHRISTOPHER JDirectorDec 16 '24Buy59.4410,000594,40036,358Dec 17 12:00 AM
Samuels Theodore R. IIDirectorDec 13 '24Buy58.865,000294,30023,000Dec 17 12:00 AM
Asher Andrew LynnChief Financial OfficerNov 13 '24Buy58.1417,2001,000,008486,847Nov 13 12:00 AM
LONDON SARAHChief Executive OfficerNov 08 '24Buy60.804,117250,314667,229Nov 08 12:00 AM
COUGHLIN CHRISTOPHER JDirectorMay 14 '24Sale76.7587867,3820May 24 12:00 AM
FASOLA KENNETH JPresidentMay 13 '24Sale77.628,000620,960300,357May 15 12:00 AM
Robinson Lori JeanDirectorFeb 13 '24Option Exercise54.6520,0001,093,00021,455Feb 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR